| NCT ID | NCT06887283 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Essen |
| Condition | Amyloidosis; Systemic |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2024-05-08 |
| Primary Completion | 2029-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2024-05-08 with a primary completion date of 2029-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Essen Amyloidosis Registry (EAR) is a prospective, observational registry designed to collect comprehensive clinical data on patients diagnosed with systemic amyloidosis. The registry aims to improve the understanding of disease progression, diagnostic pathways, and treatment outcomes. The registry is hosted at the University Hospital Essen and follows patients longitudinally. Inclusion is open to all patients with suspected or confirmed amyloidosis who provide informed consent.
Eligibility Criteria
Inclusion Criteria: * Suspected or confirmed amyloidosis (any) * Written informed consent to participate in the study * Age 18 years and above Exclusion Criteria: * Age \< 18 years * Lack of written informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06887283 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Amyloidosis; Systemic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06887283 currently recruiting?
Yes, NCT06887283 is actively recruiting participants. Contact the research team at lars.michel@uk-essen.de for enrollment information.
Where is the NCT06887283 trial being conducted?
This trial is being conducted at Essen, Germany.
Who is sponsoring the NCT06887283 clinical trial?
NCT06887283 is sponsored by University Hospital, Essen. The trial plans to enroll 400 participants.